Tirosint

Product NDC
71858-0012
11-digit product format
718580012
Labeler code
71858
Product ID
71858-0012_4ddc8742-bf50-baa5-e063-6294a90a56eb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
levothyroxine sodium
Dosage form
CAPSULE
Route
ORAL
Labeler
IBSA Pharma Inc.
Application
NDA021924
Marketing category
NDA
Marketing start
2023-03-01
Substance
LEVOTHYROXINE SODIUM
Active strength
37.5 ug/1
Pharmacologic classes
Thyroxine [CS], l-Thyroxine [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
9J765S329GLEVOTHYROXINE SODIUM6106-07-6LEVOTHYROXINE SODIUM

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71858-0012-1718580012011 BLISTER PACK in 1 CARTON (71858-0012-1) / 10 CAPSULE in 1 BLISTER PACK1 blister pack2023-03-012026-07-22YesNoHistorical
71858-0012-2718580012023 BLISTER PACK in 1 CARTON (71858-0012-2) / 10 CAPSULE in 1 BLISTER PACK3 blister pack2025-08-24YesNoHistorical
71858-0012-4718580012043 BLISTER PACK in 1 CARTON (71858-0012-4) / 10 CAPSULE in 1 BLISTER PACK3 blister pack2023-03-01NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
TirosintIBSA Pharma Inc.2026-03-25HUMAN PRESCRIPTION DRUG LABEL13